Meet TCS at World Drug Safety Congress Americas 2025

Products and Platforms

Reimagine pharmacovigilance with next-gen AI and data science

The World Drug Safety Congress (WDSC) Americas 2025 is a premier industry event that brought together global pharmacovigilance leaders, innovators, and regulatory experts to explore the future of drug safety in the age of AI.

TCS participated as a platinum Sponsor, showcasing how AI and automation are transforming pharmacovigilance operations. At booth #407, TCS featured TCS ADD™ Safety platform and its Pharmacovigilance Business Services, demonstrating how life sciences organizations can enhance efficiency, compliance, and decision-making across the drug safety value chain.

Know more about the TCS ADD™ Safety platform and TCS PV business services.

Key takeaway from the session “Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation”

AI is transforming pharmacovigilance: Generative AI is revolutionizing safety case processing, driving greater efficiency, accuracy, and decision support across the PV value chain.
Human + AI synergy build trust: The future of PV lies in leveraging AI for scale and speed while keeping experts in the loop to ensure transparency, trust, and accountability.
Redefining signal detection: AI-powered modelling is enabling earlier identification of risks and opportunities, helping detect signals in real time.

Speaker:

Sanjeev Sachdeva

Global Head, Advisory and Business Process Services, Life Sciences, Tata Consultancy Services

Sanjeev Sachdeva is the Global Head, - Advisory and Business Process Services, Life Sciences, Tata Consultancy Services. He is responsible for Life Sciences business transformation, research & innovation, advisory and future investments strategy and roadmap. With over 30+ years of experience in technology and business transformation, Sanjeev assists customers in their transformation journey by adopting new innovation technologies and processes across the business value chain - R&D, Manufacturing, Supply Chain, Digital Health, Patient Experience transformation, and Commercials. He has published various industry White Papers in Personalized Medicine, Digital Health, Quantum Computing in Life Sciences, Future of Lab, Blockchain, 5G, Metaverse in Life Sciences and Healthcare, AI in Regulated Industry, and many more.

Key takeaway from the session “Gen-AI, the frontier of a transformative PV change”

The integration of AI and Agentic AI into PV has revolutionized safety monitoring process.
As technology advances, these systems will become increasingly sophisticated, enabling real-time risk assessment and decision support.
Regulatory agencies, the Industry, and vendors will need to collaborate to establish standards and best practices for AI-driven PV products, ensuring that innovations translate into tangible benefits for patient safety.

Speaker:

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ platform

Dr. Alejandra Guerchicoff is the Industry Leader of the TCS ADD™ platform. She holds a Ph.D. in Molecular Genetics with postdoctoral training in Molecular Cardiology and Genetics of Cardiac Arrhythmias. She has 25 years of experience in medical investigation, clinical trials, and post-marketing pharmacovigilance for medical devices, drugs, combination products, gene and cell therapy, and Software as Medical Device (SaMD) products. She also authored many prestigious journal publications and books on diverse subjects. In her current role, Dr. Guerchicoff is working to develop innovative technology solutions using AI and other modern technologies across various life sciences operations.

About Us

TCS ADD™ Safety is the most innovative and validated platform in the market to handle all types of safety reports and data. The platform ensures medical context and allows submissions in customizable formats as per geo-specific regulatory requirements. Additionally, it is equipped with intelligent data analytics with actionable insights. It uses human-governed machine learning (ML) to enable AI modeling algorithms, traceability, transparency and learning management capabilities in accordance with Good Pharmacovigilance Practices (GVP).

Perpetually Adaptive Enterprise

About Us

TCS Insights

Upcoming events

Recent recognitions

Want to be a global change-maker? Join our team.

Find the latest news about TCS

Recent News

Perpetually Adaptive Enterprise

About Us

TCS Insights

Upcoming events

Recent recognitions

Want to be a global change-maker? Join our team.

Find the latest news about TCS

Recent News

Meet TCS at World Drug Safety Congress Americas 2025

Products and Platforms

Reimagine pharmacovigilance with next-gen AI and data science

Key takeaway from the session “Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation”

Speaker:

Sanjeev Sachdeva

Key takeaway from the session “Gen-AI, the frontier of a transformative PV change”

Speaker:

Dr. Alejandra Guerchicoff

Transformation starts here

Perpetually Adaptive Enterprise

About Us

TCS Insights

Upcoming events

Recent recognitions

Want to be a global change-maker? Join our team.

Find the latest news about TCS

Recent News

Products and Platforms

Reimagine pharmacovigilance with next-gen AI and data science

Key takeaway from the session “Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation”

Speaker:

Sanjeev Sachdeva

Key takeaway from the session “Gen-AI, the frontier of a transformative PV change”

Speaker:

Dr. Alejandra Guerchicoff

Related reading

Transformation starts here

Accessibility Adjustments